Centre for Addiction and Mental Health: Psychotic Disorders trials

The registry lists 38 Psychotic Disorders studies with Centre for Addiction and Mental Health as lead sponsor. 4 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 2 1Phase 4 2No phase 34(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode PsychosisNot yet recruitingNCT07777315Not applicable
• Magnetic Seizure Therapy for Schizophrenia - TrialRecruitingNCT06672588Not applicable
• Effects of NAC on Symptoms of CHR PatientsRecruitingNCT05142735Not applicable
• Switching From Twice-Daily to Once-Daily Clozapine Dosing in SchizophreniaRecruitingNCT02639702Phase 4
• Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider EngagementCompletedNCT04602741Not applicableResults posted
• Feasibility and Outcomes of a Digital Health Support for the Schizophrenia SpectrumCompletedNCT03649815Early Phase 1Results posted
• Testing the Effectiveness of The Welcome Basket InterventionCompletedNCT02946255Not applicableResults posted
• The Family Cognitive Adaptation Training Manual: A Test of EffectivenessCompletedNCT01768000Not applicableResults posted
• Effectiveness of Cognitive Remediation in a Supported Education SettingCompletedNCT01492439Not applicableResults posted
• Investigating the Muscarinic System in Schizophrenia Using Positron Emission TomographyActive, not recruitingNCT06278246
• Optimizing Mental Health for Young People at Clinical High Risk for Psychosis (CHR)CompletedNCT05757128Not applicable
• Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionCompletedNCT05300633Not applicable
• Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersCompletedNCT04418011Not applicable
• Using Short Message Service as a Means of Clinical Engagement in Early PsychosisCompletedNCT04379349Not applicable
• ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionCompletedNCT04298450Not applicable
• The Effects of Non-invasive Brain Stimulation on Treatment Adherence in SchizophreniaActive, not recruitingNCT04033679Not applicable
• Early Psychosis Intervention - Spreading Evidence-based TreatmentCompletedNCT03919760Not applicable
• Gut Microbiome in AP NaiveActive, not recruitingNCT03414151
• rTMS Treatment for Cannabis Use Disorders in PsychosisTerminatedNCT03069612Not applicable
• tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk YouthStatus unknownNCT02951208Not applicable
• RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient SettingCompletedNCT02950571Not applicable
• Topiramate and Schizophrenia: Effects on Weight and PsychopathologyActive, not recruitingNCT02808533Not applicable
• Switching Antipsychotics: Abrupt Discontinuation Versus OverlapCompletedNCT02640300Phase 4
• Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic SymptomsStatus unknownNCT02529163Not applicable
• A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for PsychosisCompletedNCT02430935Not applicable
• An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic IllnessCompletedNCT02130596Not applicable
• Brief Motivational Enhancement Therapy for Concurrent DisordersTerminatedNCT01924039Not applicable
• rTMS for Working Memory Deficits in SchizophreniaCompletedNCT01880255Not applicable
• Lifestyle Intervention for Diabetes and Weight Management in PsychosisCompletedNCT01828931Not applicable
• Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive DisorderCompletedNCT01596608Not applicable
• Effect of Varenicline on Cognitive Function in Cigarette Smokers With SchizophreniaCompletedNCT01093365Phase 2
• Prevention of Weight Gain in Early PsychosesCompletedNCT01075295Not applicable
• Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With SchizophreniaStatus unknownNCT00825045Not applicable
• 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET StudyCompletedNCT00818298Not applicable
• Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.CompletedNCT00716755Not applicable
• Anticholinergic Burden in SchizophreniaTerminatedNCT00715377Not applicable
• Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With SchizophreniaCompletedNCT00407277Not applicable
• Tetrabenazine for Partial RespondersCompletedNCT00362804Not applicable